<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Suzuki H</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Podoplanin, a mucin-like transmembrane glycoprotein, is reportedly expressed in a variety of malignant cells and is generally regarded as a factor for promoting tumor progression in conventional studies. By contrast, a clinicopathologically conflicting role for podoplanin, namely as a favorable prognostic factor for patients with lung/cervical squamous cell carcinoma (SCC), has recently been reported. Here, we investigated the role of podoplanin expressed in lung squamoid cancer cells (LSCCs) in experimental tumor progression.&lt;h4>Results&lt;/h4>Using EBC-1 cells, a lung SCC cell line without podoplanin expression and with lymphogenous metastatic potential, stable transformants with or without an exogenous human podoplanin gene were established and applied to a mouse tumor i</pubmed_abstract><journal>Molecular cancer</journal><pagination>287</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2987985</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Podoplanin in cancer cells is experimentally able to attenuate prolymphangiogenic and lymphogenous metastatic potentials of lung squamoid cancer cells.</pubmed_title><pmcid>PMC2987985</pmcid><pubmed_authors>Maehara Y</pubmed_authors><pubmed_authors>Yonemitsu Y</pubmed_authors><pubmed_authors>Onimaru M</pubmed_authors><pubmed_authors>Sueishi K</pubmed_authors><pubmed_authors>Nakamura S</pubmed_authors><pubmed_authors>Suzuki H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Podoplanin in cancer cells is experimentally able to attenuate prolymphangiogenic and lymphogenous metastatic potentials of lung squamoid cancer cells.</name><description>&lt;h4>Background&lt;/h4>Podoplanin, a mucin-like transmembrane glycoprotein, is reportedly expressed in a variety of malignant cells and is generally regarded as a factor for promoting tumor progression in conventional studies. By contrast, a clinicopathologically conflicting role for podoplanin, namely as a favorable prognostic factor for patients with lung/cervical squamous cell carcinoma (SCC), has recently been reported. Here, we investigated the role of podoplanin expressed in lung squamoid cancer cells (LSCCs) in experimental tumor progression.&lt;h4>Results&lt;/h4>Using EBC-1 cells, a lung SCC cell line without podoplanin expression and with lymphogenous metastatic potential, stable transformants with or without an exogenous human podoplanin gene were established and applied to a mouse tumor i</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Oct</publication><modification>2025-04-05T00:26:56.35Z</modification><creation>2019-03-27T00:36:47Z</creation></dates><accession>S-EPMC2987985</accession><cross_references><pubmed>21034514</pubmed><doi>10.1186/1476-4598-9-287</doi></cross_references></HashMap>